-
Charlie Puth and Ellie Goulding to Headline First Johnnie & Co. Festival in Mumbai
-
ALIX LASERS shareholders remove Michael Sobitsch as managing director in view of the circumstances
-
Maryland Woman Arrested in Decade-Long Cancer Scam Involving Fake Medical Team
-
Panthers Seek NFC South Lead Against Ravens as Baltimore Ends Skid
-
Alset AI Closes Non-Brokered Private Placement Offering
-
5 Fun Date Night Ideas That Don't Cost a Fortune
-
The DEA Laid The Trap - And State Marijuana Operators Took The Bait
-
Tosca's 2026 Sustainability Report Makes the Case for Packaging as Critical Supply Chain Infrastructure
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 20
-
Ryde Group Ltd Announces Non-Binding Term Sheet for Proposed Minority Investment in Multi Genius Limited and MOU on Technology Collaboration
-
American Resources Corporation and ReElement Technologies Selected as Part of Winning U.S.-Led Consortium for Kenya's Strategic Mrima Hill Critical Minerals Project
-
barq Signs MoU with TenPay Global to Enhance Remittances and Digital Payments in China
-
Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
-
PodcastOne (NASDAQ:PODC) Launches People Pleasers Podcast hosted by Comedians Leah Rudick and Jessica Michelle Singleton
-
Who Does the Best Rhinoplasty in Sarasota?
-
Arrive AI's Pro Forma Stockholders' Equity Now Above Nasdaq Minimum Requirement Following Recent Transactions
-
AI Search Engineers Says Longer AI Mode Questions Mean Professional Service Firms Should Answer Full Client Questions Directly on Their Pages
-
American Businessman Mark Eric Williams Vindicated in Six-Year, US$150 Million-Plus Litigation Brought by Kuwaiti State Entities
-
Dateline appoints Tony Ferguson as Acting Chairman
-
Closing a Business with Payroll Taxes Owed - Clear Start Tax Explains the Trust Fund Recovery Penalty
-
AsiaFIN Holdings Corp. Appoints Fortune Angel INC as U.S. Reseller Partner to Expand Its Agentic and Robotic Process Automation SaaS Business Across New York and the East Coast
-
Cytta Air Expands Military Contracting Expertise - Appoints Rear Admiral James "Gib" Godwin III to Advisory Board
-
Commonhold Explained: How New Leasehold Ban Changes Property Ownership in England and Wales
-
Factory Worker Dies in Rare Rectal Explosion Incident in Czechia
-
GIRLBAND! Headline Show at Rough Trade Marks National Breakthrough
-
Decoding UNFCCC Legal Language: The Hierarchy of Verbs in Climate Negotiations
-
Saudi PIF Retains Top Sovereign Wealth Fund Brand Title for Third Year
New Horizon Medical Solutions Announces A New Tri-Layer Product Offering Expanding Portfolio
New Horizon Medical Solutions unveils Xceed™ TL Matrix: A game-changing innovation in wound care
LAS VEGAS, NV / ACCESS Newswire / October 15, 2025 / New Horizon Medical Solutions (NHMS) today announced the launch of Xceed TL Matrix, a tri-layer placental-derived allograft, a groundbreaking addition to its wound care portfolio. This versatile, safe and effective product is designed to enhance wound management, emphasizing five core areas: consistency, advanced material composition, strength, the incorporation of an extracellular matrix, and reliability.

Consistency
Xceed TL Matrix (Xceed TL) delivers reliable performance and uniformity in wound care, offering healthcare professionals a product they can trust, designed to provide optimal results. The tri-layer structure is meticulously engineered to maintain moisture balance, promoting a wound care environment that can help minimize the risk of complications.
Thick chorion layer
At the heart of Xceed TL is a dense chorion core, which serves as the foundation for its advanced moisture management capabilities. This thick chorion layer effectively retains moisture and acts as a barrier against external contaminants, creating an optimal environment that can support faster recovery times.
Strength
The added amnion layer enhances the tensile strength and handling properties of the Xceed TL product. This addition not only boosts the product's durability, making it resistant to tearing, but also improves its user-friendliness. Providers can confidently apply and adjust the dressing, ensuring it remains secure while providing essential protection for the wound.
Extracellular matrix
Xceed TL features a natural scaffold rich in extracellular matrix (ECM), which supports native structural components. This integration of ECM, an important component in natural tissue structure, elevates the product's performance in wound care.
Reliability
With a trusted, proven and tested design, Xceed TL stands out as a dependable solution for healthcare providers. Its robust construction and demonstrated performance are consistent with the high standards expected in clinical settings, fostering confidence in patient care.
"We are committed to advancing wound care solutions that empower healthcare providers and improve patient outcomes," said D. Christopher Keil, SVP, strategy and corporate development, New Horizon Medical Solutions. "The introduction of Xceed TL reflects our dedication to forward thinking in wound care, quality and excellence in medical solutions."
Xceed TL is available now through New Horizon. For more information or to schedule a call, please visit our website at www.nhmedical.com or contact New Horizon directly at [email protected] or at 725-232-6167.
About New Horizon Medical Solutions
New Horizon Medical Solutions (NHMS), a leader in advanced wound care technologies, develops and delivers biologically derived human placental allograft products designed to meet the highest standards of safety and performance. New Horizon's portfolio spans amniotic membranes, placental tissues, and skin grafts for chronic wounds, surgical reconstruction, burns, and orthopedic procedures. Through evidence-based design and precision manufacturing, NHMS delivers solutions that align with real-world clinical practices and improve patient outcomes. www.nhmedical.com
--
Media contact
Julian Rogers
Director of Corporate Marketing
[email protected]
702-960-2913
SOURCE: New Horizon Medical Solutions
View the original press release on ACCESS Newswire
F.Ramirez--AT